212 related articles for article (PubMed ID: 34974056)
1. Risk factors for Coronavirus disease-associated mucormycosis.
Arora U; Priyadarshi M; Katiyar V; Soneja M; Garg P; Gupta I; Bharadiya V; Berry P; Ghosh T; Patel L; Sarda R; Garg S; Agarwal S; Arora V; Ramprasad A; Kumar A; Garg RK; Kodan P; Nischal N; Singh G; Jorwal P; Kumar A; Baitha U; Meena VP; Ray A; Sethi P; Xess I; Vikram N; Sinha S; Biswas A; Thakar A; Bhatnagar S; Trikha A; Wig N
J Infect; 2022 Mar; 84(3):383-390. PubMed ID: 34974056
[TBL] [Abstract][Full Text] [Related]
2. Coronavirus disease-associated mucormycosis (CAM): A case control study during the outbreak in India.
Wasiq M; K R; Gn A
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443518
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for COVID-19 associated mucormycosis in India: A case control study.
Patel AK; Bakshi H; Shah K; Patel S; Patel T; Patel K; Patel KK
Med Mycol; 2022 Jul; 60(7):. PubMed ID: 35709394
[TBL] [Abstract][Full Text] [Related]
4. A case control investigation of COVID-19 associated mucormycosis in India.
Anand T; Mukherjee A; Satija A; Velamuri PS; Singh KJ; Das M; Josten K; Yadav PD; Sahay RR; Keche AY; Nagarkar NM; Gupta P; Himanshu D; Mistry SN; Patel JD; Rao P; Rohatgi S; Ghosh S; Hazra A; Kindo AJ; Annamalai R; Rudramurthy SM; Singh MP; Shameem M; Fatima N; Khambholja JR; Parikh S; Madkaikar M; Pradhan VD; Kataria S; Sharma P; Panda S;
BMC Infect Dis; 2022 Nov; 22(1):856. PubMed ID: 36384482
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors of COVID-19 Associated Mucormycosis (CAM) in Iranian Patients: A Single-Center Retrospective Study.
Tavakolpour S; Irani S; Yekaninejad MS; Alimardi M; Hasibi M; Abdollahi H; Kazemi MA; Lotfi M; Shahbazian H; Nazemian Yazdi NA; Samimiardestani S; Firouzifar M; Farahbakhsh F; Mirzaee Goodarzi M; Feiz F; Salehinia F
Mycopathologia; 2022 Dec; 187(5-6):469-479. PubMed ID: 36202942
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India.
Dravid A; Kashiva R; Khan Z; Bande B; Memon D; Kodre A; Mane M; Pawar V; Patil D; Kalyani S; Raut P; Bapte M; Saldanha C; Chandak D; Patil T; Reddy S; Bhayani K; Suresh L; Dillibabu V; Srivastava S; Khandelwal S; More S; Shakeel A; Pawar M; Nande P; Harshe A; Kadam S; Hallikar S; Kamal N; Andrabi D; Bodhale S; Raut A; Chandrashekhar S; Raman C; Mahajan U; Joshi G; Mane D
Mycoses; 2022 May; 65(5):526-540. PubMed ID: 35212032
[TBL] [Abstract][Full Text] [Related]
7. Multicenter Epidemiologic Study of Coronavirus Disease-Associated Mucormycosis, India.
Patel A; Agarwal R; Rudramurthy SM; Shevkani M; Xess I; Sharma R; Savio J; Sethuraman N; Madan S; Shastri P; Thangaraju D; Marak R; Tadepalli K; Savaj P; Sunavala A; Gupta N; Singhal T; Muthu V; Chakrabarti A;
Emerg Infect Dis; 2021 Sep; 27(9):2349-2359. PubMed ID: 34087089
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology, Clinical Profile, and Analysis of Risk Factors in COVID Associated Rhino-orbito-cerebral Mucormycosis Patients - An Observational Study.
Jog K; Nazirudeen R; Eagappan S; Santharam RK; Sridhar S
Indian J Endocrinol Metab; 2023; 27(6):519-523. PubMed ID: 38371190
[TBL] [Abstract][Full Text] [Related]
9. Serum iron indices in COVID-19-associated mucormycosis: A case-control study.
Kumar H M; Sharma P; Rudramurthy SM; Sehgal IS; Prasad KT; Pannu AK; Das R; Panda NK; Sharma N; Chakrabarti A; Agarwal R; Muthu V
Mycoses; 2022 Jan; 65(1):120-127. PubMed ID: 34743358
[TBL] [Abstract][Full Text] [Related]
10. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
[TBL] [Abstract][Full Text] [Related]
11. COVID-19-associated Mucormycosis: A clinico-epidemiological study.
Chakravarty J; Gupta MK; Tilak R; Kumar R; Maurya RP; Kumar N; Aggarwal SK; S S; Sharma NK; Dhiman NK; Chaubey M; Singh V; Verma A; Banerjee T; Agrawal NK; Prasad RS
J Diabetes Complications; 2022 Sep; 36(9):108284. PubMed ID: 35987108
[TBL] [Abstract][Full Text] [Related]
12. Clinical-epidemiological Profile of Coronavirus Disease 19 Associated Mucomycosis (CAM) and Relation with Zinc and Iron Levels.
Karoli R; Kulshreshtha MR; Gupta N; Singh M; Singh V; Shakya S
J Assoc Physicians India; 2022 Feb; 70(2):11-12. PubMed ID: 35436818
[TBL] [Abstract][Full Text] [Related]
13. Cumulative Mortality and Factors Associated With Outcomes of Mucormycosis After COVID-19 at a Multispecialty Tertiary Care Center in India.
Choksi T; Agrawal A; Date P; Rathod D; Gharat A; Ingole A; Chaudhari B; Pawar N
JAMA Ophthalmol; 2022 Jan; 140(1):66-72. PubMed ID: 34882192
[TBL] [Abstract][Full Text] [Related]
14. Diabetes and Covid Associated Mucormucormycosis-A Cross Sectional Study in Kilpauk Medical College.
Pradeepkumar V
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443380
[TBL] [Abstract][Full Text] [Related]
15. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India.
Vasanthapuram VH; Gupta R; Adulkar N; Nair AG; Bradoo RA; Hegde R; Singh U; Tadepalli S; Mukherjee B; Kamal S; Alam MS; Rao R; Ananthakrishna S; Backiavathy V; Murthy AK; D'Cunha L; Dudeja G; Joji A; Kiran A; Koka K; Goswami Mukhopadhyay M; Nisar SP; Rao PR; Shinde CA
Orbit; 2023 Feb; 42(1):30-41. PubMed ID: 35192435
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology and Pathophysiology of COVID-19-Associated Mucormycosis: India Versus the Rest of the World.
Muthu V; Rudramurthy SM; Chakrabarti A; Agarwal R
Mycopathologia; 2021 Dec; 186(6):739-754. PubMed ID: 34414555
[TBL] [Abstract][Full Text] [Related]
17. Incidence, cumulative mortality and factors affecting the outcome of COVID-19-associated mucormycosis from Western India.
Vare AA; Yellambkar S; Farheen A; Nandedkar V; Bhombe SS; Shah R
Indian J Ophthalmol; 2021 Dec; 69(12):3678-3683. PubMed ID: 34827021
[TBL] [Abstract][Full Text] [Related]
18. Association of Serum Iron Studies in COVID Associated Mucormycosis with Stage of the Disease.
Rao C; R M
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443509
[TBL] [Abstract][Full Text] [Related]
19. Cerebrovascular Involvement in Mucormycosis in COVID-19 Pandemic.
Kulkarni R; Pujari SS; Gupta D; Ojha P; Dhamne M; Bolegave V; Dhonde P; Soni A; Adwani S; Diwan A; Duberkar D; Batra D; Deshpande R; Aurangabadkar K; Palasdeokar N
J Stroke Cerebrovasc Dis; 2022 Feb; 31(2):106231. PubMed ID: 34890962
[TBL] [Abstract][Full Text] [Related]
20. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India.
Singh AK; Singh R; Joshi SR; Misra A
Diabetes Metab Syndr; 2021; 15(4):102146. PubMed ID: 34192610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
